Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Theralase Technologies (TLT) Stock Price & Analysis

99 Followers

TLT Stock Chart & Stats

CA$0.19CA$0.01(2.78%)
At close: 4:00 PM EST
C$0.175C$0.2C$0.225C$0.25Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
CAD 0.19 - CAD 0.19
52-Week Range
CAD 0.15 - CAD 0.41
Previous Close
CAD 0.18
Volume
N/A
Average Volume (3M)
101.31K
Market Cap
CAD 55.89M
Enterprise Value
CAD 67.31M
Total Cash (Recent Filing)
CAD 5.26M
Total Debt (Recent Filing)
CAD 148.72K
Price to Earnings (P/E)
―
Beta
-0.05
Next Earnings
Dec 02, 2026 (Est.)
EPS Estimate
-0
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

The very low debt burden reduces refinancing pressure and preserves financial flexibility relative to a more leveraged medical technology company. This gives Theralase greater capacity to direct future capital toward laser commercialization and PDT development rather than servicing substantial fixed obligations.

Improved Gross Margin

Improvement in gross margin indicates that product economics have strengthened relative to the prior period, even though the current revenue base remains too small to cover operating costs. If sustained alongside revenue expansion, better gross profitability could support eventual operating leverage.

Dual Technology Platforms

Theralase combines a medical-device platform with a pharmaceutical R&D program, creating two potential avenues for long-term value creation. Successful progress in either area could expand commercialization opportunities, while the broader platform provides strategic optionality beyond a single product.

Bears Say

Contracting Revenue

A small and declining revenue base limits operating scale and suggests that current commercialization has not yet produced durable growth. Continued contraction makes it harder to absorb fixed costs, fund product development internally, and establish a stronger base for sustainable earnings.

Deep Profitability Deficit

The magnitude and persistence of losses show that current revenue is far below the level needed to support the company’s cost structure. Without a clear operating-leverage inflection, ongoing deficits can erode equity value and constrain investment in the laser and PDT programs.

Persistent Cash Burn

Materially negative operating and free cash flow indicate that Theralase is not currently self-funding its operations. Continued burn relative to revenue increases dependence on external funding over time and may limit the company’s ability to sustain development and commercialization without additional capital.

Theralase Technologies News

TLT FAQ

What was Theralase Technologies’s price range in the past 12 months?
Theralase Technologies lowest stock price was C$0.15 and its highest was C$0.41 in the past 12 months.
What is Theralase Technologies’s market cap?
Theralase Technologies’s market cap is C$55.89M.
When is Theralase Technologies’s upcoming earnings report date?
Theralase Technologies’s next earnings report is estimated for Dec 02, 2026 (not yet confirmed), which is in 27 days.
How were Theralase Technologies’s earnings last quarter?
Theralase Technologies released its earnings results on Aug 28, 2026. The company reported -C$0.003 earnings per share for the quarter.
Is Theralase Technologies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Theralase Technologies pay dividends?
Theralase Technologies does not currently pay dividends.
What is Theralase Technologies’s EPS estimate?
Theralase Technologies’s EPS estimate is -0.00.
How many shares outstanding does Theralase Technologies have?
Theralase Technologies has 310,483,300 shares outstanding.
What happened to Theralase Technologies’s price movement after its last earnings report?
Theralase Technologies reported an EPS of -C$0.003 in its last earnings report. Following the earnings report the stock price went down -2.703%.
Which hedge fund is a major shareholder of Theralase Technologies?
Currently, no hedge funds are holding shares in TSE:TLT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology